Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35788823.
- Also identified by DOI 10.1093/bib/bbac269 and PMC identifier 9353967.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Predicting the drug-target interaction is crucial for drug discovery as well as drug repurposing. Machine learning is commonly used in drug-target affinity (DTA) problem. However, the machine learning model faces the cold-start problem where the model performance drops when predicting the interaction of a novel drug or target. Previous works try to solve the cold start problem by learning the drug or target representation using unsupervised learning. While the drug or target representation can be learned in an unsupervised manner, it still lacks the interaction information, which is critical in drug-target interaction. To incorporate the interaction information into the drug and protein interaction, we proposed using transfer learning from chemical-chemical interaction (CCI) and protein-protein interaction (PPI) task to drug-target interaction task. The representation learned by CCI and PPI tasks can be transferred smoothly to the DTA task due to the similar nature of the tasks. The result on the DTA datasets shows that our proposed method has advantages compared to other pre-training methods in the DTA task.
Medical subject headings
- Drug Development
- Machine Learning